Survey of long-term follow-up programs in the United States for survivors of childhood brain tumors

Pediatric Blood and Cancer

Volumn 53, Issue 7, 2009, Pages 1295-1301

  Bowers, Daniel C ^a   Adhikari, Soumya ^a   El Khashab, Yasmin M ^b   Gargan, Lynn ^b   Oeffinger, Kevin C ^c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b CHILDREN S MEDICAL CENTER   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Childhood brain tumors; Growth hormone; Late effects; Medulloblastoma; Survivorship

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE;

ARTICLE; BRAIN TUMOR; CANCER RADIOTHERAPY; CANCER SURVIVOR; CHILD; CHILDHOOD CANCER; HEALTH SURVEY; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MEDULLOBLASTOMA; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; UNITED STATES; ADULT; AFTERCARE; AMBULATORY CARE; BRAIN DISEASE; CANCER CENTER; CHRONIC DISEASE; ECONOMICS; FEMALE; FOLLOW UP; INFORMATION PROCESSING; INSURANCE; MALE; MEDICAL SOCIETY; ORGANIZATION AND MANAGEMENT; OUTPATIENT DEPARTMENT; PATIENT PARTICIPATION; PITUITARY DWARFISM; PSYCHOLOGICAL ASPECT; RADIATION INJURY; SKULL IRRADIATION; STATISTICS; SURVIVOR;

ADULT; AFTERCARE; AMBULATORY CARE; BRAIN DISEASES; BRAIN NEOPLASMS; CHILD; CHRONIC DISEASE; CRANIAL IRRADIATION; DATA COLLECTION; DWARFISM, PITUITARY; FEMALE; FOLLOW-UP STUDIES; HUMAN GROWTH HORMONE; HUMANS; INSURANCE BENEFITS; MALE; MEDULLOBLASTOMA; NEUROPSYCHOLOGICAL TESTS; ONCOLOGY SERVICE, HOSPITAL; OUTPATIENT CLINICS, HOSPITAL; PATIENT PARTICIPATION; RADIATION INJURIES; SOCIETIES, MEDICAL; SURVIVORS; UNITED STATES;

EID: 70449707690     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22240     Document Type: Article

References (34)

1. Hewitt M,Weiner SL, Simone JV. Childhood cancer survivorship: Improving care and quality of life.Washington, DC: The National Academies Press; 2003.
2. Mariotto A, Rowland J, Yabroff K, et al. Long-term survivors of childhood cancers in the United States. Cancer Epidemiol Biomarkers Prev 2009;18:1033-1040.
3. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006;355:1572-1582.
4. Hewitt M, Greenfield S, Stovall E. Institute of medicine: From cancer patient to cancer survivor: Lost in translation. Washington, DC: The National Academies Press; 2005.
5. Ries LAG, Eisner MP, Kosary CL, et al. SEER cancer statistics review, 1975-2001. Bethesda, MD: National Cancer Institute; 2004.
6. Packer RJ, Gurney JG, Punyko JA, et al. Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: Childhood Cancer Survivor Study. J Clin Oncol 2003;21:3255-3261.
7. Maddrey AM, Bergeron JA, Lombardo ER, et al. Neuropsychological performance and quality of life of 10 year survivors of childhood medulloblastoma. J Neuro-Oncol 2005;72:245-253.
8. Mulhern RK, Palmer SL, Reddick WE, et al. Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss. J Clin Oncol 2001;19:472-479.
9. Palmer SL, Goloubeva O, Reddick WE, et al. Patterns of intellectual development among survivors of pediatric medulloblastoma: A longitudinal analysis. J Clin Oncol 2001;19:2302-2308.
10. Gurney JG, Kadan-Lottick NS, Packer RJ, et al. Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: A report from the Childhood Cancer Survivor Study. Cancer 2003;97:663-673.
11. Sklar CA, Constine LS. Chronic neuroendocrinological sequelae of radiation therapy. Int J Radiat Oncol Biol Phys 1995;31:1113-1121.
12. Lustig RH, Post SR, Srivannaboon K, et al. Risk factors for the development of obesity in children surviving brain tumors. J Clin Endocrinol Metab 2003;88:611-616.
13. Morris EB, Gajjar A, Okuma JO, et al. Survival and late mortality in long-term survivors of pediatric CNS tumors. J Clin Oncol 2007;25:1532-1538.
14. Mitby PA, Robison LL, Whitton JA, et al. Utilization of special education services and educational attainment among long-term survivors of childhood cancer. Cancer 2003;97:1115-1126.
15. Taylor L, Simpson K, Bushardt R, et al. Insurance barriers for childhood survivors of pediatric brain tumors: The case for neurocognitive evaluations. Pediatr Neurosurg 2006;42:223-227.
16. Mulhern R, Kepner J, Thomas P, et al. Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: A Pediatric Oncology Group study. J Clin Oncol 1998;16:1723-1728.
17. Rappaport R, Brauner R. Growth and endocrine disorders secondary to cranial irradiation. Pediatr Res 1989;25: 561-567.
18. Walter AW, Mulhern RK, Gajjar A, et al. Survival and neurodevelopmental outcome of young children with medulloblastoma at St Jude Children's Research Hospital. J Clin Oncol 1999;17:3720-3728.
19. Packer RJ, Boyett JM, Janss AJ, et al. Growth hormone replacement therapy in children with medulloblastoma: Use and effect on tumor control. J Clin Oncol 2001;19:480-487.
20. Fradkin JE, Mills JL, Schonberger LB, et al. Risk of leukemia after treatment with pituitary growth hormone. JAMA 1993;270:2829-2832.
21. Sklar CA, Mertens AC, Mitby P, et al. Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: A report from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2002;87:3136-3141.
22. Swerdlow AJ, Reddingius RE, Higgins CD, et al. Growth hormone treatment of children with brain tumors and risk of tumor recurrence. J Clin Endocrinol Metab 2000;85:4444-4449.
23. Nishi Y, Tanaka T, Takano K, et al. Recent status in the occurrence of leukemia in growth hormone-treated patients in Japan. J Clin Endocrinol Metab 1999;84:1961-1965.
24. Wilson T, Rose S, Cohen P, et al. Update of guidelines for the use of growth hormone in children: The Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee. J Pediatr 2003;143:415-421.
25. Nicolson A, Toogood A, Rahim A, et al. The prevalence of severe growth hormone deficiency in adults who received growth hormone replacement in childhood. Clin Endocrinol (Oxf) 1996;44:311-316.
26. Ho K, Participants GDCW. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: A statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. Eur J Endocrinol 2007;157:695-700.
27. Torres CF, Rebsamen S, Silber JH, et al. Surveillance scanning of children with medulloblastoma. N Engl J Med 1994;330:892-895.
28. Friedman HS, Kun LE. More on surveillance of children with medulloblastoma. N Engl J Med 1995;332:191.
29. Neglia J, Robison L, Stovall M, et al. Newprimary neoplasms of the central nervous system in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. J Nat Cancer Inst 2006;98:1528-1537.
30. Oeffinger KC, HamishW,Wallace B. Barriers to follow-up care of survivors in the United States and the United Kingdom. Pediatr Blood Cancer 2006;46:135-142.
31. Nathan P, Greenberg M, Ness K, et al. Medical care in long-term survivors of childhood cancer:Areport from the Childhood Cancer Survivor Study. J Clin Oncol 2008;26:4401-4409.
32. MacLean WE, FoleyGV, Ruccinone K, et al. Transitions in the care of adolescent and young adult survivors of childhood cancer. Cancer 1996;78:1340-1344.
33. Zebrack BJ, Eshelman DA, Hudson MM, et al. Health care for childhood cancer survivors. Cancer 2004;100:843-850.
34. Oeffinger KC, Eshelman DA, Tomlinson GE, et al. Programs for adult survivors of childhood cancer. J Clin Oncol 1998;16:2864-2867.